Evidence map›Paper›PMID 41939349›Full record

ArticleACS omega2026

MFDR-DTI: Multisource Feature Decoupling and Dual-Level Reorganization Fusion for Accurate Drug-Target Interaction Prediction.

Dan Xie, Xue Yu, Yuni Zeng, Qi Dai

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dan XieCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.ORCID https://orcid.org/0009-0005-8458-1109
Xue YuCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Yuni ZengSchool of Computer Science and Technology, Zhejiang Sci-Tech University, Hangzhou 310018, China.ORCID https://orcid.org/0009-0007-1613-810X
Qi DaiCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Predicting drug-target interactions is crucial for accelerating modern drug discovery. Although deep learning-based approaches have achieved significant progress, effectively integrating biochemical features originating from heterogeneous data sources and multilevel representations remains a major challenge. To address this limitation, this paper proposes MFDR-DTI, a DTI prediction framework based on Multisource Feature Decoupling Representation and a Dual-level dynamic Reorganization Fusion Mechanism. The framework innovatively decouples features into three orthogonal spacestopological structure, physicochemical properties, and contextual semanticsand integrates them through the dual-level dynamic reorganization fusion mechanism, which consists of homogeneous feature integration and a shared-weight cross-property attention network. To tackle the imbalance in contribution among different feature branches during training, we design an adaptive collaborative optimization strategy based on gradient statistics, which dynamically adjusts the weight of each branch's loss term according to its real-time impact on the global objective, thereby improving convergence efficiency and training stability. Comprehensive experiments on multiple widely used data sets demonstrate that MFDR-DTI consistently outperforms various state-of-the-art baseline models across multiple evaluation metrics. Ablation studies further verify that each proposed component positively contributes to improving prediction accuracy and enhancing generalization capability.

Identifiers

PMID41939349
PMCPMC13044623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.